RhumbLine Advisers’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3
| Closed | -$17 | – | 4378 |
|
|
2023
Q2 | $17 | Buy |
+3
| New | +$17 | ﹤0.01% | 4382 |
|
|
2022
Q2 | – | Sell |
-2,616
| Closed | -$73K | – | 3286 |
|
|
2022
Q1 | $73K | Sell |
2,616
-134
| -5% | -$3.74K | ﹤0.01% | 2942 |
|
|
2021
Q4 | $125K | Sell |
2,750
-14
| -0.5% | -$636 | ﹤0.01% | 2914 |
|
|
2021
Q3 | $230K | Buy |
2,764
+69
| +3% | +$5.74K | ﹤0.01% | 2858 |
|
|
2021
Q2 | $256K | Buy |
+2,695
| New | +$256K | ﹤0.01% | 2851 |
|
|
2014
Q2 | – | Sell |
-17
| Closed | -$37K | – | 3078 |
|
|
2014
Q1 | $37K | Sell |
17
-1
| -6% | -$2.18K | ﹤0.01% | 2969 |
|
|
2013
Q4 | $42K | Hold |
18
| – | – | ﹤0.01% | 3003 |
|
|
2013
Q3 | $51K | Hold |
18
| – | – | ﹤0.01% | 2970 |
|
|
2013
Q2 | $170K | Buy |
+18
| New | +$170K | ﹤0.01% | 3066 |
|